Neurocrine Biosciences, Inc.

NBIX ·Healthcare, Drug Manufacturers - General, United States

← 5Y 10Y MAX →

Shares Outstanding

Fiscal Year	Shares Outstanding
FY2017	88.1M
FY2018	95.4M
FY2019	95.7M
FY2020	97.8M
FY2021	97.9M
FY2022	98.9M
FY2023	101.0M
FY2024	103.7M
FY2025	102.5M
FY2026	100.4M